Andrea Antinori

Andrea Antinori publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Andrea Antinori sits on this spectrum.

Andrea Antinori D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Andrea Antinori sits on this spectrum.

Best Publications

• Updated research nosology for HIV-associated neurocognitive disorders

  A. Antinori;G. Arendt;J. T. Becker;B. J. Brew

  3098
  Citations

• Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

  Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  1068
  Citations

• Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients.

  A d'Arminio Monforte;A C Lepri;G Rezza;P Pezzotti

  785
  Citations

• Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection.

  Adriana Ammassari;Rita Murri;Patrizio Pezzotti;Maria Paola Trotta

  673
  Citations

• Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature.

  Adriana Ammassari;Maria Paola Trotta;Rita Murri;Francesco Castelli

  672
  Citations

• Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

  Bonaventura Clotet;Judith Feinberg;Jan Van Lunzen;Marie Aude Khuong-Josses

  630
  Citations

• Late presentation of HIV infection: a consensus definition

  A Antinori;T Coenen;D Costagiola;N Dedes

  627
  Citations

• Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

  Linda Wittkop;Huldrych F Günthard;Frank de Wolf;David Dunn

  492
  Citations

• Coformulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection (GS-US-380–1490): a randomised, double-blind, multicentre, phase 3, non-inferiority trial

  Paul E. Sax;Anton Pozniak;M. Luisa Montes;Ellen Koenig

  433
  Citations

• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

  Unknown

  428
  Citations

• Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

  Valerio Tozzi;Pietro Balestra;Rita Bellagamba;Angela Corpolongo

  399
  Citations

• Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons.

  Adriana Ammassari;Andrea Antinori;Maria Stella Aloisi;Maria Paola Trotta

  392
  Citations

• Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy.

  Fabrizio Starace;Adriana Ammassari;Maria Paola Trotta;Rita Murri

  357
  Citations

• Diagnosis of AIDS-related focal brain lesions A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF

  Andrea Antinori;A. Ammassari;A. De Luca;A. Cingolani

  334
  Citations

• All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration

  Charlotte Lewden;Vincent Bouteloup;Stéphane De Wit

  326
  Citations

• CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study

  Cristina Mussini;Patrizia Lorenzini;Alessandro Cozzi-Lepri;Giuseppe Lapadula

  325
  Citations

• Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

  Antonella Cingolani;Andrea Antinori;Maria Gabriella Rizzo;Rita Murri

  316
  Citations

• Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

  John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  287
  Citations

• Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity

  Unknown

  280
  Citations

• Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy.

  Andrea Antinori;Antonella Cingolani;Lucia Alba;Adriana Ammassari

  273
  Citations